Skip Navigation



Hum. Reprod. Advance Access published online on May 19, 2005
Human Reproduction, doi:10.1093/humrep/dei072
This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
20/9/2457    most recent
dei072v2
dei072v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ibáñez, L.
Right arrow Articles by de Zegher, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ibáñez, L.
Right arrow Articles by de Zegher, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org
Received February 21, 2005
Revised March 28, 2005
Accepted April 15, 2005

Article

High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception

Lourdes Ibáñez 1*, Adriana Maria Jaramillo 1, Angela Ferrer 1, and Francis de Zegher 2

1 Endocrinology Unit, Hospital Sant Joan de Déu, University of Barcelona, Spain
2 Department of Pediatrics, University of Leuven, Belgium

* To whom correspondence should be addressed.
Lourdes Ibáñez, E-mail: libanez{at}hsjdbcn.org


  Abstract

BACKGROUND: The endocrine hallmark of polycystic ovary syndrome (PCOS) is hyperinsulinaemic hyperandrogenism; another facet of PCOS is low-grade inflammation. METHODS: In adolescents and young women with hyperinsulinaemic hyperandrogenism (n=118; mean age 16 years, body mass index 22 kg/m2), we analysed whether the PCOS-associated rise in leukocyte count is already detectable at young age and, if so, whether such elevation is lowered by metformin, flutamide-metformin, oral contraception (OC), or their combination. RESULTS: Leukocyte count (x1000/mm3) in patients was high versus controls (7.5 ± 0.1 versus 6.4 ± 0.1; P < 0.001) due to a rise in neutrophils (4.2 ± 0.1 versus 3.0 ± 0.1; P < 0.001). Randomized studies at mean ages of 12.5 years (n=24) and 15.2 years (n=33) demonstrated normalizing effects of metformin (850 mg/day; P < 0.001) and, respectively, metformin plus flutamide (62.5 mg/day) on neutrophil counts; in young women (18.3 years; n=41), the neutrophil count rose further on OC monotherapy (P=0.003), but normalized on the same OC plus flutamide-metformin (P < 0.001 versus OC alone). CONCLUSIONS: (i) A high leukocyte count is already present in girls with hyperinsulinaemic hyperandrogenism, and this is due to a raised neutrophil count; (ii) this hyperneutrophilia is attenuated by metformin or flutamide-metformin, and is amplified by OC monotherapy; (iii) if these treatments are combined, the normalizing effect of flutamide-metformin overcomes the OC effect on neutrophil count.

Keywords: flutamide; leukocytosis; metformin; oral contraception; ovarian hyperandrogenism.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
F. Orio, F. Manguso, S. Di Biase, A. Falbo, F. Giallauria, D. Labella, A. Tolino, G. Lombardi, A. Colao, and S. Palomba
Metformin administration improves leukocyte count in women with polycystic ovary syndrome: a 6-month prospective study
Eur. J. Endocrinol., July 1, 2007; 157(1): 69 - 73.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Ibanez, A. Lopez-Bermejo, L. del Rio, G. Enriquez, C. Valls, and F. de Zegher
Combined Low-Dose Pioglitazone, Flutamide, and Metformin for Women with Androgen Excess
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1710 - 1714.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Ibanez, K. Ong, D. B. Dunger, and F. de Zegher
Early Development of Adiposity and Insulin Resistance after Catch-Up Weight Gain in Small-for-Gestational-Age Children
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2153 - 2158.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
L. Ibanez and F. de Zegher
Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women
Hum. Reprod. Update, May 1, 2006; 12(3): 243 - 252.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
L. Ibanez, K. Ong, D. B. Dunger, and F. d. Zegher
Effects of Growth Hormone Treatment on Neutrophil Count in Children Born Small for Gestational Age
Pediatrics, May 1, 2006; 117(5): 1868 - 1869.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
L. Ibanez, C. Valls, and F. de Zegher
Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-{alpha} and the neutrophil/lymphocyte ratio
Hum. Reprod., February 1, 2006; 21(2): 451 - 456.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. J. Puder, S. Varga, M. Kraenzlin, C. De Geyter, U. Keller, and B. Muller
Central Fat Excess in Polycystic Ovary Syndrome: Relation to Low-Grade Inflammation and Insulin Resistance
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6014 - 6021.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.